Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 267, pseudogene (RNU6-267P) is a pseudogene of the U6 small nuclear RNA family[1][4]. Pseudogenes are genomic sequences similar to known genes but are generally non-functional due to accumulated mutations or inability to be properly expressed. U6 small nuclear RNAs (snRNAs) themselves are essential components of the spliceosome, playing a critical role in pre-mRNA splicing by facilitating the removal of introns from pre-mRNA transcripts[3]. However, as a pseudogene, RNU6-267P is presumed not to produce a functional RNA or protein product and does not participate in canonical spliceosomal activities[1][4]. There is no evidence that RNU6-267P functions as a therapeutic target, nor are there known disease associations, relevant biomarkers, interacting drugs, or established biological roles. Summary: - RNU6-267P is a non-coding RNA pseudogene, not known to be involved in disease, drug interactions, or to have a functional role in cell biology, and is not considered a therapeutic target[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 267, pseudogene (RNU6-267P).